Ad
ACRS Quote Trading Chart Aclaris Therapeutics Inc.
home / stock / acrs / acrs quote
$16.80 Last:
5.2% Change Percent:
$16.93 Open:
$15.97 Previous Close:
$17.095 High:
$16.7 Low:
542,927 Volume:
12/31/1969 07:00:00 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
ACRS Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2022-08-12 | 16.93 | 15.97 | 17.095 | 16.7 | 542,927 |
| 2022-08-11 | 16.93 | 15.97 | 17.21 | 16.65 | 237,215 |
| 2022-08-10 | 18 | 15.97 | 18 | 16.9 | 282,990 |
| 2022-08-09 | 17.94 | 15.97 | 18.37 | 17.46 | 441,458 |
| 2022-08-08 | 18.18 | 15.97 | 18.59 | 17.7 | 466,813 |
| 2022-08-05 | 16.42 | 15.97 | 18.46 | 16.29 | 378,068 |
| 2022-08-04 | 14.65 | 15.97 | 16.86 | 14.4 | 309,223 |
| 2022-08-03 | 14.19 | 15.97 | 14.77 | 13.6571 | 427,293 |
| 2022-08-02 | 13.54 | 15.97 | 14.22 | 13.43 | 257,400 |
| 2022-08-01 | 15.41 | 15.97 | 15.41 | 13.56 | 412,321 |
| 2022-07-29 | 15.73 | 15.97 | 15.73 | 15.0763 | 233,044 |
| 2022-07-28 | 15.97 | 15.97 | 15.99 | 14.91 | 264,530 |
| 2022-07-26 | 15.32 | 15.32 | 15.5 | 14.5698 | 38,960 |
| 2022-07-25 | 15.13 | 15.36 | 15.5 | 14.75 | 188,869 |
| 2022-07-19 | 15.37 | 16.11 | 16.385 | 15.19 | 229,065 |
| 2022-07-18 | 15.37 | 15.07 | 15.65 | 14.87 | 187,681 |
| 2022-07-15 | 15.31 | 15.24 | 15.46 | 14.585 | 193,816 |
| 2022-07-14 | 15.6 | 15.22 | 15.705 | 15.15 | 141,654 |
| 2022-07-13 | 14.96 | 15.84 | 15.9554 | 14.795 | 164,385 |
| 2022-07-12 | 15.49 | 15.32 | 15.8 | 15 | 298,266 |
Aclaris Therapeutics Inc. Company Name:
ACRS Stock Symbol:
NASDAQ Market:
Aclaris Therapeutics Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
Ad
-
WAYNE, Pa., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced its financial results for the second quarter of 2022 and provided...
-
WAYNE, Pa., June 01, 2022 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that Dr. Neal Walker, President and CEO of Aclaris, will particip...
-
WAYNE, Pa., May 16, 2022 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that Dr. Neal Walker, President and CEO of Aclaris, will virtually...